Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette

D E Newby1, A L McLeod, N G Uren

  • 1Departments of Cardiology, University of Edinburgh, Royal Infirmary, United Kingdom. d.e.newby@ed.ac.uk

Circulation
|April 18, 2001
PubMed

Insights

Coronary artery plaque and smoking impair the heart's ability to release tissue plasminogen activator (tPA). This reduced fibrinolytic capacity is linked to endothelial dysfunction and may affect heart attack treatment in smokers.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Thrombosis

Background:

  • Atherosclerosis and smoking are known risk factors for cardiovascular disease.
  • The impact of coronary atheroma and smoking on stimulated tissue plasminogen activator (tPA) release is not fully understood.

Purpose of the Study:

  • To investigate the influence of proximal coronary artery atheroma and smoking on the stimulated release of tPA from the heart.
  • To explore the relationship between plaque burden, smoking, and local fibrinolytic capacity.

Main Methods:

  • 25 patients underwent coronary angiography, with proximal LAD plaque volume assessed by IVUS.
  • Fibrinolytic responses to substance P and sodium nitroprusside were measured via intracoronary infusion and blood sampling.
  • Coronary blood flow and tPA antigen/activity were analyzed.

Main Results:

  • Increased plaque burden in the LAD was inversely correlated with active tPA release (r=-0.61, P=0.003).
  • Current and ex-smokers showed significantly impaired coronary release of active tPA compared to non-smokers (P<0.05).
  • Substance P infusion increased tPA release, while sodium nitroprusside increased blood flow.

Conclusions:

  • Coronary atheromatous plaque burden and smoking habit are associated with reduced local fibrinolytic capacity.
  • Findings suggest a link between endogenous fibrinolysis, endothelial dysfunction, and atherothrombosis.
  • These factors may explain variations in thrombolytic therapy efficacy for myocardial infarction in smokers.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...